Marimed (MRMD) 10% Owner Jon R. Levine Receives RSU Shares

What Happened

• Jon R. Levine, reported as a 10% owner of Marimed, had RSUs vest and convert into 30,625 shares of common stock on July 15, 2026. Of those, 10,612 shares were withheld to satisfy tax withholding (disposed) for a reported value of $703. The underlying derivative awards (the RSUs) were extinguished upon conversion.

Key Details

• Transaction date: July 15, 2026; Form 4 filed July 17, 2026 (filed in the routine two-day window).
• Actions reported: conversion/exercise of derivative (code M) — 30,625 RSUs converted to common shares; tax withholding (code F) — 10,612 shares surrendered at $0.07/share ($703).
• Net shares delivered to the reporting person: 20,013 shares (30,625 vested − 10,612 withheld).
• Shares owned after the transaction: not specified in the filing.
• Footnotes: F1–F4 note that RSUs convert one-for-one to common stock, shares were withheld for tax obligations, some shares are held in trust for the reporting person’s spouse and children (and disclaimed), and the RSU grant vests in additional installments (Oct 15, 2026; Jan 15, 2027; Apr 15, 2027).

Context

• This was a scheduled RSU vesting/conversion and a routine tax-withholding surrender of shares — not an open-market buy or sale. The filing shows no cash purchase or open-market sale by the reporting person; as a 10% owner this activity is a reported award vesting under Section 16 rules.